Meals and snacks with "GLP-1 Friendly" labels on the packaging are becoming more common in U.S
Another growing demographic consists of aging adults - typically in their 40s to 70s - who are becoming more aware of the connection between energy, metabolism, and healthy aging
Some studies suggest that GLP-1 agonists may reduce the risk of cardiovascular events, like heart attacks and strokes, which is especially beneficial for people with diabetes or metabolic syndrome
These physical symptoms can sometimes trigger or exacerbate anxiety in susceptible individuals, particularly when severe or persistent
He has received honoraria for talks sponsored by Bayer, Bial, Boston Scientific, and Novo Nordisk
Are other GLP-1 drugs safer for bones